Glaucoma, the major reason for irretrievable loss of sight, is a complex condition wherein injury of the optic nerve leads to loss of the eye sight progressively. Today, over 3 million individuals in American region are existing with glaucoma, and this figure is likely to become twofold by 2050.
The only existing permitted therapy for glaucoma is to lower intraocular pressure (IOP), that can be accomplished by administering eyedrops, laser therapy, or rarely with surgical interference. Eye drops are the utmost commonly prescribed treatment option.
Large population are unaware of the condition
In many situations, an individual suffering from glaucoma is not aware of any symptoms of the disorders or loss of sight. This is because glaucoma is painless, and the symptoms of the vision loss is only noticed in the latter stages of the condition. And only as les as 50% of those diagnosed with glaucoma have any symptoms. In case of elderly population, the loss of vision is generally attributed to just growing old. Loss of sight due to glaucoma is hushed, slow, progressive, and irreversible.
In US, more than 3 million people are suffering with glaucoma and half of the them do not realize about the condition. According to the studies of the Glaucoma Research Foundation, this population is expected to increase up to 58% by 2030. Likewise, in Italy, one in two individuals are unaware about their condition and it is assessed that nearly 500,000 people are suffering with glaucoma.
This condition in no different in Australia. Half of the 300,000 individuals in Australia are unaware that they are suffering from a possibly blinding ailment as the symptoms are not noticeable and have not had an eye checkup. 90% of loss of sight can be prevented with the help of eye-drops and rarely with surgery only if detected at an early stage.
– Rikitha K Murthy,